As the prevalence of advanced heart failure continues to rise, treatment strategies for select
patients include heart transplantation or durable left ventricular assist device (LVAD) …

Left ventricular assist device (LVAD) therapy is a lifesaving option for patients with medical
therapy-refractory advanced heart failure. Depending on the definition, 5–44% of people …

Durable implantable left ventricular assist devices (LVADs) have been shown to improve
survival and quality of life for patients with stage D heart failure. Even though LVADs remain …

Knowledge of right ventricular (RV) structure and function has historically lagged behind that
of the left ventricle (LV). However, advancements in invasive and non-invasive evaluations …

The HeartWare HVAD System (Medtronic) is a durable left ventricular assist device (LVAD)
approved for bridge to transplant indication in 2012 and destination therapy indication in …

BACKGROUND Conventional median sternotomy (CMS) is still the standard technique
utilized to implant left ventricular assist devices (LVADs). Recent studies suggest that less …

Left ventricular assist devices (LVADs) are increasingly common across the heart failure
population. Right ventricular failure (RVF) is a feared complication that can occur in the early …

Background Nearly 1000 permanent ventricular assist devices (VADs) are implanted in
patients with severe congestive heart failure in Germany each year. VADs are miniaturized …

Background Left ventricular assist devices (LVADs) have improved outcomes for selected
patients with advanced heart failure, but alternative optimal surgical techniques remain to be …

Aims Temporal changes in patient selection and major technological developments have
occurred in the field of left ventricular assist devices (LVADs), yet analyses depicting this …